Do analysts rate ISPC or IPM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Intelligent Protection Management 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer ISPC or TGHL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 GrowHub 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, ISPC or TGHL?

iSpecimen has higher revenue and earnings than GrowHub. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 1.92 -$10.49M -$72.26 N/A GrowHub $60K 253.00 -$13.38M N/A N/A

Is ISPC or TGHL more profitable?

GrowHub has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. GrowHub's return on equity of 0.00% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets iSpecimen -1,080.16% -584.65% -142.48% GrowHub N/A N/A N/A

Do analysts prefer ISPC or TC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Token Cat 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, ISPC or TC?

Token Cat has lower revenue, but higher earnings than iSpecimen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 1.92 -$10.49M -$72.26 N/A Token Cat $850K 4.74 $320K N/A N/A

Is ISPC or TC more profitable?

Token Cat has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Token Cat's return on equity of 0.00% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets iSpecimen -1,080.16% -584.65% -142.48% Token Cat N/A N/A N/A

Do analysts rate SWVL or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Swvl 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, SWVL or ISPC?

Swvl has higher revenue and earnings than iSpecimen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Swvl $24.17M 0.64 $1.31M N/A N/A iSpecimen $1.93M 1.92 -$10.49M -$72.26 N/A

Is SWVL or ISPC more profitable?

Swvl has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Swvl's return on equity of 0.00% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets Swvl N/A N/A N/A iSpecimen -1,080.16% -584.65% -142.48%

Do analysts recommend BTOC or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Armlogi 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, BTOC or ISPC?

iSpecimen has lower revenue, but higher earnings than Armlogi. Armlogi is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Armlogi $190.41M 0.07 -$15.35M -$0.47 N/A iSpecimen $1.93M 1.92 -$10.49M -$72.26 N/A

Is BTOC or ISPC more profitable?

Armlogi has a net margin of -10.70% compared to iSpecimen's net margin of -1,080.16%. Armlogi's return on equity of -104.33% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets Armlogi -10.70% -104.33% -13.30% iSpecimen -1,080.16% -584.65% -142.48%

iSpecimen (ISPC) Competitors

$2.57 -0.07 (-2.65%)

Closing price 04:00 PM Eastern

Extended Trading

$2.58 +0.02 (+0.58%)

As of 07:53 PM Eastern

Compare

ISPC vs. IPM, TGHL, TC, SWVL, and BTOC

Should you buy iSpecimen stock or one of its competitors? MarketBeat compares iSpecimen with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iSpecimen include Intelligent Protection Management (IPM), GrowHub (TGHL), Token Cat (TC), Swvl (SWVL), and Armlogi (BTOC). These companies are all part of the "business services" industry.

How does iSpecimen compare to Intelligent Protection Management?

iSpecimen (NASDAQ:ISPC) and Intelligent Protection Management (NASDAQ:IPM) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

Intelligent Protection Management has a net margin of -14.01% compared to iSpecimen's net margin of -1,080.16%. Intelligent Protection Management's return on equity of -18.44% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-1,080.16%	-584.65%	-142.48%
Intelligent Protection Management	-14.01%	-18.44%	-12.16%

In the previous week, Intelligent Protection Management had 1 more articles in the media than iSpecimen. MarketBeat recorded 1 mentions for Intelligent Protection Management and 0 mentions for iSpecimen. iSpecimen's average media sentiment score of 0.00 equaled Intelligent Protection Management'saverage media sentiment score.

Company	Overall Sentiment
iSpecimen	Neutral
Intelligent Protection Management	Neutral

Intelligent Protection Management has higher revenue and earnings than iSpecimen. Intelligent Protection Management is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	1.92	-$10.49M	-$72.26	N/A
Intelligent Protection Management	$23.61M	0.66	-$1.96M	-$0.26	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Intelligent Protection Management	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

iSpecimen has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, Intelligent Protection Management has a beta of 0.46, meaning that its stock price is 54% less volatile than the broader market.

13.6% of iSpecimen shares are owned by institutional investors. Comparatively, 3.9% of Intelligent Protection Management shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by company insiders. Comparatively, 20.8% of Intelligent Protection Management shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Intelligent Protection Management beats iSpecimen on 8 of the 11 factors compared between the two stocks.

How does iSpecimen compare to GrowHub?

iSpecimen (NASDAQ:ISPC) and GrowHub (NASDAQ:TGHL) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
GrowHub	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

13.6% of iSpecimen shares are held by institutional investors. 12.2% of iSpecimen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

iSpecimen has higher revenue and earnings than GrowHub.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	1.92	-$10.49M	-$72.26	N/A
GrowHub	$60K	253.00	-$13.38M	N/A	N/A

GrowHub has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. GrowHub's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-1,080.16%	-584.65%	-142.48%
GrowHub	N/A	N/A	N/A

In the previous week, iSpecimen's average media sentiment score of 0.00 equaled GrowHub'saverage media sentiment score.

Company	Overall Sentiment
iSpecimen	Neutral
GrowHub	Neutral

Summary

iSpecimen and GrowHub tied by winning 4 of the 8 factors compared between the two stocks.

How does iSpecimen compare to Token Cat?

iSpecimen (NASDAQ:ISPC) and Token Cat (NASDAQ:TC) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Token Cat has lower revenue, but higher earnings than iSpecimen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	1.92	-$10.49M	-$72.26	N/A
Token Cat	$850K	4.74	$320K	N/A	N/A

13.6% of iSpecimen shares are held by institutional investors. Comparatively, 8.9% of Token Cat shares are held by institutional investors. 12.2% of iSpecimen shares are held by company insiders. Comparatively, 0.5% of Token Cat shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Token Cat has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Token Cat's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-1,080.16%	-584.65%	-142.48%
Token Cat	N/A	N/A	N/A

In the previous week, Token Cat had 17 more articles in the media than iSpecimen. MarketBeat recorded 17 mentions for Token Cat and 0 mentions for iSpecimen. iSpecimen's average media sentiment score of 0.00 equaled Token Cat'saverage media sentiment score.

Company	Overall Sentiment
iSpecimen	Neutral
Token Cat	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Token Cat	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

iSpecimen has a beta of 1.63, indicating that its share price is 63% more volatile than the broader market. Comparatively, Token Cat has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

Summary

Token Cat beats iSpecimen on 6 of the 10 factors compared between the two stocks.

How does iSpecimen compare to Swvl?

Swvl (NASDAQ:SWVL) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

Swvl has higher revenue and earnings than iSpecimen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Swvl	$24.17M	0.64	$1.31M	N/A	N/A
iSpecimen	$1.93M	1.92	-$10.49M	-$72.26	N/A

34.0% of Swvl shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 29.9% of Swvl shares are owned by company insiders. Comparatively, 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Swvl has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, iSpecimen has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market.

In the previous week, Swvl had 2 more articles in the media than iSpecimen. MarketBeat recorded 2 mentions for Swvl and 0 mentions for iSpecimen. Swvl's average media sentiment score of 0.59 beat iSpecimen's score of 0.00 indicating that Swvl is being referred to more favorably in the media.

Company	Overall Sentiment
Swvl	Positive
iSpecimen	Neutral

Swvl has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Swvl's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Swvl	N/A	N/A	N/A
iSpecimen	-1,080.16%	-584.65%	-142.48%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Swvl	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Swvl beats iSpecimen on 9 of the 11 factors compared between the two stocks.

How does iSpecimen compare to Armlogi?

Armlogi (NASDAQ:BTOC) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Armlogi	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

13.6% of iSpecimen shares are held by institutional investors. 66.9% of Armlogi shares are held by insiders. Comparatively, 12.2% of iSpecimen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Armlogi's average media sentiment score of 0.00 equaled iSpecimen'saverage media sentiment score.

Company	Overall Sentiment
Armlogi	Neutral
iSpecimen	Neutral

Armlogi has a net margin of -10.70% compared to iSpecimen's net margin of -1,080.16%. Armlogi's return on equity of -104.33% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Armlogi	-10.70%	-104.33%	-13.30%
iSpecimen	-1,080.16%	-584.65%	-142.48%

iSpecimen has lower revenue, but higher earnings than Armlogi. Armlogi is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Armlogi	$190.41M	0.07	-$15.35M	-$0.47	N/A
iSpecimen	$1.93M	1.92	-$10.49M	-$72.26	N/A

Armlogi has a beta of 2.75, indicating that its share price is 175% more volatile than the broader market. Comparatively, iSpecimen has a beta of 1.63, indicating that its share price is 63% more volatile than the broader market.

Summary

Armlogi beats iSpecimen on 7 of the 10 factors compared between the two stocks.

Get iSpecimen News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ISPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ISPC vs. The Competition

Export

Metric	iSpecimen	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.79M	$9.43B	$6.92B	$12.59B
Dividend Yield	N/A	1.62%	2.66%	6.52%
P/E Ratio	-0.04	27.37	27.35	24.81
Price / Sales	1.92	25.92	507.73	89.92
Price / Cash	N/A	15.44	29.65	49.23
Price / Book	0.18	6.26	11.06	6.50
Net Income	-$10.49M	$177.20M	$3.57B	$336.03M
7 Day Performance	-7.89%	6.20%	2.56%	2.68%
1 Month Performance	-14.90%	13.03%	7.39%	5.50%
1 Year Performance	-93.70%	15.06%	34.13%	25.01%

iSpecimen Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ISPC iSpecimen	0.4651 of 5 stars	$2.57 -2.7%	N/A	-93.5%	$3.79M	$1.93M	N/A	60	Positive News
IPM Intelligent Protection Management	1.3765 of 5 stars	$1.74 +1.2%	N/A	-9.5%	$15.54M	$23.61M	N/A	20	Gap Up
TGHL GrowHub	N/A	$0.60 +8.7%	N/A	N/A	$13.89M	$60K	N/A	12
TC Token Cat	0.234 of 5 stars	$1.85 -76.9%	N/A	-81.4%	$13.86M	$850K	N/A	620	Gap Up High Trading Volume
SWVL Swvl	1.0592 of 5 stars	$1.34 -3.2%	N/A	-66.5%	$13.71M	$24.17M	N/A	2	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ISPC) was last updated on 7/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iSpecimen (ISPC) Competitors

ISPC vs. IPM, TGHL, TC, SWVL, and BTOC

How does iSpecimen compare to Intelligent Protection Management?

Summary

How does iSpecimen compare to GrowHub?

Summary

How does iSpecimen compare to Token Cat?

Summary

How does iSpecimen compare to Swvl?

Summary

How does iSpecimen compare to Armlogi?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ISPC vs. The Competition

iSpecimen Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iSpecimen (ISPC) Competitors

ISPC vs. IPM, TGHL, TC, SWVL, and BTOC

How does iSpecimen compare to Intelligent Protection Management?

Is ISPC or IPM more profitable?

Does the media refer more to ISPC or IPM?

Which has preferable valuation & earnings, ISPC or IPM?

Do analysts rate ISPC or IPM?

Which has more risk and volatility, ISPC or IPM?

Do insiders & institutionals hold more shares of ISPC or IPM?

Summary

How does iSpecimen compare to GrowHub?

Do analysts prefer ISPC or TGHL?

Do institutionals & insiders hold more shares of ISPC or TGHL?

Which has stronger valuation & earnings, ISPC or TGHL?

Is ISPC or TGHL more profitable?

Does the media prefer ISPC or TGHL?

Summary

How does iSpecimen compare to Token Cat?

Which has stronger valuation & earnings, ISPC or TC?

Do institutionals & insiders hold more shares of ISPC or TC?

Is ISPC or TC more profitable?

Does the media refer more to ISPC or TC?

Do analysts prefer ISPC or TC?

Which has more volatility and risk, ISPC or TC?

Summary

How does iSpecimen compare to Swvl?

Which has better earnings and valuation, SWVL or ISPC?

Do institutionals & insiders have more ownership in SWVL or ISPC?

Which has more risk and volatility, SWVL or ISPC?

Does the media favor SWVL or ISPC?

Is SWVL or ISPC more profitable?

Do analysts rate SWVL or ISPC?

Summary

How does iSpecimen compare to Armlogi?

Do analysts recommend BTOC or ISPC?

Do insiders & institutionals have more ownership in BTOC or ISPC?

Does the media favor BTOC or ISPC?

Is BTOC or ISPC more profitable?

Which has better valuation & earnings, BTOC or ISPC?

Which has more risk and volatility, BTOC or ISPC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ISPC vs. The Competition

iSpecimen Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools